keyword
https://read.qxmd.com/read/38637871/bilateral-wilms-tumor-with-anaplasia-a-report-from-the-children-s-oncology-group-study-aren0534
#1
JOURNAL ARTICLE
Rodrigo L P Romao, Jennifer H Aldrink, Lindsay A Renfro, Elizabeth A Mullen, Andrew J Murphy, Jack Brzezinski, Marcus M Malek, Daniel J Benedetti, Nicholas G Cost, Ethan Smith, Jeffrey S Dome, Andrew M Davidoff, Amy Treece, Lauren N Parsons, Conrad V Fernandez, Brett Tornwall, Robert C Shamberger, Arnold Paulino, John A Kalapurakal, James I Geller, Peter F Ehrlich
INTRODUCTION: The purpose of this study is to examine the outcomes in children with anaplastic bilateral Wilms tumor (BWT) from study AREN0534 in order to define potential prognostic factors and areas to target in future clinical trials. METHODS: Demographic and clinical data from AREN0534 study patients with anaplasia (focal anaplasia [FA], or diffuse anaplasia [DA]) were compared. Event-free survival (EFS) and overall survival (OS) were reported using Kaplan-Meier estimation with 95% confidence bands, and differences in outcomes between FA and DA compared using log-rank tests...
April 18, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38629258/off-label-prescribing-of-immune-checkpoint-inhibitor-therapy-at-a-single-pediatric-cancer-center
#2
JOURNAL ARTICLE
Ajami Gikandi, Susan N Chi, Kee Kiat Yeo, Allison F O'Neill, David S Shulman, Steven G DuBois, Natalie B Collins
BACKGROUND: Immune checkpoint inhibitors (ICI) have improved outcomes in a variety of adult cancers and are prescribed with increasing frequency across oncology. However, patterns of off-label use of ICI in pediatrics remain unclear. METHODS: This is a single-institution, retrospective cohort study evaluating off-label ICI use in pediatric and young adult patients with cancer treated at our institution from 2014 to 2022. Response was based on clinician assessment derived from clinical records...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38627882/event-free-survival-in-relapsed-and-refractory-rhabdomyosarcoma-treated-on-cooperative-group-phase-ii-trials-a-report-from-the-children-s-oncology-group
#3
JOURNAL ARTICLE
Jonathan Metts, Wei Xue, Zhengya Gao, Sapna Oberoi, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
BACKGROUND: Novel therapies are needed for relapsed and refractory rhabdomyosarcoma (RRMS). Phase II clinical trials in RRMS have typically utilized radiologic response as the primary activity endpoint, an approach that poses several limitations in RRMS. In this analysis, we aimed to estimate an event-free survival (EFS) endpoint for RRMS that could be used as a benchmark for future studies. PROCEDURE: We performed a retrospective study of patients with RRMS enrolling on 13 single-agent phase II Children's Oncology Group and legacy group trials from 1997 to 2016...
April 16, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38612645/the-clinical-relevance-of-the-eph-ephrin-signaling-pathway-in-pediatric-solid-and-hematologic-malignancies
#4
REVIEW
Elena Chatzikalil, Ioanna E Stergiou, Stavros P Papadakos, Ippokratis Konstantinidis, Stamatios Theocharis
Pediatric neoplasms represent a complex group of malignancies that pose unique challenges in terms of diagnosis, treatment, and understanding of the underlying molecular pathogenetic mechanisms. Erythropoietin-producing hepatocellular receptors (EPHs), the largest family of receptor tyrosine kinases and their membrane-tethered ligands, ephrins, orchestrate short-distance cell-cell signaling and are intricately involved in cell-pattern morphogenesis and various developmental processes. Unraveling the role of the EPH/ephrin signaling pathway in the pathophysiology of pediatric neoplasms and its clinical implications can contribute to deciphering the intricate landscape of these malignancies...
March 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38610794/pre-exposure-prophylaxis-and-treatment-with-tixagevimab-cilgavimab-for-covid-19-among-immunocompromised-pediatric-patients
#5
JOURNAL ARTICLE
Jowita Frączkiewicz, Katarzyna Pawińska-Wąsikowska, Katarzyna Szymbor, Walentyna Balwierz, Szymon Skoczeń, Krzysztof Czyżewski, Sylwia Kołtan, Jan Styczyński, Anna Małecka, Ninela Irga-Jaworska, Joanna Trelińska, Wojciech Młynarski, Olga Zając-Spychała, Agnieszka Sobkowiak-Sobierajska, Katarzyna Derwich, Wioletta Bal, Radosław Chaber, Agnieszka Książek, Tomasz Szczepański, Joanna Zawitkowska, Katarzyna Drabko, Agnieszka Chodała-Grzywacz, Grażyna Karolczyk, Christopher Kobierzycki, Krzysztof Kałwak
Background: Patients treated with hemato-oncological malignancies (HO) or undergoing cellular therapies such as hematopoietic stem cell transplantation (HSCT) or chimeric antigen receptor T cells (CAR-T) were significantly affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the success of SARS-CoV-2 vaccination, immunocompromised patients remain at increased risk for severe coronavirus disease (COVID-19), rendering this group of population a high priority for additional prevention and treatment options...
March 31, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38605554/anaplasia-in-wilms-tumor-a-critical-review
#6
REVIEW
Gordan M Vujanić, William Mifsud
Anaplasia in Wilms tumor is recognized as the most important prognostically unfavorable histological feature. It is subtyped as focal anaplastic Wilms tumor (FAWT) and diffuse anaplastic Wilms tumor (DAWT). Outcomes of patients with DAWT remain poor in patients with stage III and IV tumors. Important issues relevant to anaplasia in Wilms tumor, including prevalence, treatment, outcomes, biomarkers, anaplasia, and chemotherapy, and the concept of tumor aggressiveness, are reviewed and discussed here. We also consider the differences in clinical approaches to anaplasia in Wilms tumor between the two major renal tumor clinical research groups: the International Society of Paediatric Oncology (SIOP) Renal Tumour Study Group and the Children's Oncology Group (COG) Renal Tumor Group...
April 11, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38605546/development-of-a-blueprint-for-sibling-psychosocial-services-a-nationwide-study
#7
JOURNAL ARTICLE
Kathryn A Davis, Marcella Mazzenga, Phoebe Brosnan Hall, David Buchbinder, Melissa A Alderfer, Anjali R Oberoi, Christina M Sharkey, Ariel O Blakey, Kristin A Long
BACKGROUND: Siblings of youth with cancer have heightened risk for poor long-term psychosocial outcomes. Although sibling psychosocial care is a standard in pediatric oncology, this standard is among those least likely to be met. To address barriers to providing sibling services, a blueprint for systematic psychosocial screening and support of siblings was developed based on feedback from a national sample of psychosocial providers. PROCEDURE: Semi-structured interviews were conducted with a purposive sample of psychosocial care providers (N = 27) of various disciplines working in US pediatric cancer centers, varied in size, type, and extent of sibling support...
April 11, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38605511/results-of-a-long-term-prospective-study-on-complications-of-central-venous-catheter-in-pediatric-patients-with-hematologic-oncologic-diseases
#8
JOURNAL ARTICLE
Chiara Garonzi, Francesca Zeni, Gloria Tridello, Alice Giacomazzi, Alberto Castagna, Maria Pia Esposto, Giulia Caddeo, Vincenza Pezzella, Ada Zaccaron, Elisa Bonetti, Virginia Vitale, Matteo Chinello, Rita Balter, Beatrice Guardini, Eleonora Pedrazzoli, Simone Cesaro
BACKGROUND: Central venous catheter (CVC)-related complications remain a significant cause of morbidity in pediatric hematology-oncology. We prospectively surveyed the incidence of CVC-related complications in children with hematologic-oncologic diseases. PROCEDURE: Five-hundred-eighty-one CVCs were inserted in 421 patients from January 2010 to June 2022 (153,731 CVC days observation; follow-up data up to December 31, 2022). RESULTS: Overall, 671 complications were recorded (4...
April 11, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38600340/eclim-sehop-how-to-develop-a-platform-to-conduct-academic-trials-for-childhood-cancer
#9
JOURNAL ARTICLE
Antonio Juan-Ribelles, Francisco Bautista, Adela Cañete, Alba Rubio-San-Simón, Anna Alonso-Saladrigues, Raquel Hladun, Susana Rives, Jose Luís Dapena, Jose María Fernández, Álvaro Lassaletta, Ofelia Cruz, Gemma Ramírez-Villar, Jose Luís Fuster, Cristina Diaz de Heredia, Miguel García-Ariza, Eduardo Quiroga, María Del Mar Andrés, Jaime Verdú-Amorós, Antonio Molinés, Blanca Herrero, Mónica López, Catalina Márquez, María Toboso, Frencisco Lendínez, Jose Gómez Sirvent, María Tallón, Guiomar Rodríguez, Tomás Acha, Lucas Moreno, Ana Fernández-Teijeiro
INTRODUCTION: ECLIM-SEHOP platform was created in 2017. Its main objective is to establish the infrastructure to allow Spanish participation into international academic collaborative clinical trials, observational studies, and registries in pediatric oncology. The aim of this manuscript is to describe the activity conducted by ECLIM-SEHOP since its creation. METHODS: The platform's database was queried to provide an overview of the studies integrally and partially supported by the organization...
April 10, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38595820/case-report-therapy-related-myeloid-neoplasms-in-three-pediatric-cases-with-medulloblastoma
#10
Li Shun Mak, Xiuling Li, Wilson Y K Chan, Alex W K Leung, Daniel K L Cheuk, Liz Y P Yuen, Jason C C So, Shau Yin Ha, Anthony P Y Liu
INTRODUCTION: Medulloblastoma is the most common malignant brain tumor in children, often requiring intensive multimodal therapy, including chemotherapy with alkylating agents. However, therapy-related complications, such as therapy-related myeloid neoplasms (t-MNs), can arise, particularly in patients with genetic predisposition syndromes. This case report presents three pediatric cases of medulloblastoma with subsequent development of t-MNs, highlighting the potential role of genetic predisposition and the importance of surveillance for hematological abnormalities in long-term survivors...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38587477/characterizing-age-related-differences-in-hodgkin-lymphoma-in-children-adolescents-and-young-adults
#11
JOURNAL ARTICLE
Nicole E Kendel, Joseph R Stanek, Faye K Willen, Anthony N Audino
Current studies describing younger children with Hodgkin lymphoma are limited by geographical region, small sample sizes and variable age groups. Although published data is lacking, there appears to be a trend toward a higher male to female ratio and a higher proportion of mixed cellularity subtype when compared to older cohorts. We performed a retrospective multicenter study utilizing the Pediatric Health Information System® database to evaluate patients aged 0-39 years with Hodgkin lymphoma. We identified 3,034 unique patients who met inclusion criteria...
April 8, 2024: Pediatric Hematology and Oncology
https://read.qxmd.com/read/38583546/a-systematic-review-and-meta-analysis-of-the-effectiveness-of-primary-thromboprophylaxis-in-acute-lymphoblastic-leukemia-during-early-phase-therapy-including-asparaginase-or-its-prolonged-form
#12
REVIEW
Zhongbo Hu, Yogindra Persaud, Sanjay Ahuja
Asparaginase is essential in the initial management of acute lymphoblastic leukemia (ALL) but frequently leads to venous thromboembolism (VTE). Using anticoagulants for primary VTE prevention has been studied with no consensus. We conducted a systematic literature search in PubMed, Scopus, and Web of science and performed random-effect meta-analysis using Mantel-Haenszel method in RevMan 5.4 to analyze primary pharmacological thromboprophylaxis during asparaginase treatment in early-phase (induction, consolidation, or intensification phase) therapy in patients with ALL with all ages and followed with subgroup analysis by age...
April 5, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38573005/the-diagnostic-performance-of-magnetic-resonance-imaging-in-the-categorization-of-pediatric-neck-lymph-nodes-radiologic-and-pathologic-correlations
#13
JOURNAL ARTICLE
Emine Caliskan, Naz Paytoncu, Hanife G Düzkalır, Meral Arifoglu, Neriman Fistikcioglu, Hediye P Gunbey
BACKGROUND/AIM: To present MRI features of neck lymph nodes in benign and malignant conditions in the pediatric population. MATERIALS AND METHODS: MRIs of the neck of 51 patients aged 1 to 18 years (40 boys, 11 girls [10.08±4.73]) with lymph node biopsy were retrospectively analyzed. Those were grouped as benign including reactive (27 [52.9%]) and lymphadenitis (11 [21.6%]), and malignant (13 [25.5%]). The groups were evaluated multiparametrically in terms of quantitative and qualitative variables...
April 4, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38573000/very-long-term-survivorship-in-pediatric-dipg-case-report-and-review-of-the-literature
#14
JOURNAL ARTICLE
Evan Dimentberg, Marie-Pier Marceau, Alexandre Lachance, Samuel Bergeron-Gravel, Stephan Saikali, Louis Crevier, Catherine Bourget, Cynthia Hawkins, Nada Jabado, Panagiota Giannakouros, Samuele Renzi, Valérie Larouche
Diffuse intrinsic pontine gliomas are lethal tumors with a prognosis generally less than 1 year. Few cases of survivors of 5 years or more have been reported. This case report highlights the journey of a 9.5-year survivor who underwent 3 rounds of focal radiotherapy; she experienced 6 years of progression-free survival following the first round but ultimately succumbed to her disease. An autopsy revealed a favorable IDH1 mutation and the absence of H3K27M. This case reiterates the importance of extensive molecular analyses in diffuse intrinsic pontine gliomas and explores the potential benefit of re-irradiation in patients with positive responses and long periods of remission...
April 4, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38572993/a-single-center-experience-of-radiotherapy-in-pediatric-ewing-sarcoma-primitive-neuroectodermal-tumor-of-the-chest-wall
#15
JOURNAL ARTICLE
Ecem Yigit, Melis Gultekin, Burca Aydin, Tezer Kutluk, Sezin Yuce Sari, Saniye Ekinci, Diclehan Orhan, Ferah Yildiz
AIM: To evaluate the treatment results, prognostic parameters, and treatment-related toxicity in patients with Ewing sarcoma (ES)/primitive neuroectodermal tumor (PNET) of the chest wall who underwent surgery, chemotherapy, and radiotherapy (RT) in a tertiary referral center. METHODS: The data of 24 patients under 18 years of age with a histologic diagnosis of ES/PNET in the chest wall that received RT in our department between February 2003 and July 2020 were retrospectively evaluated...
April 3, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38564328/the-ras-signaling-pathway-mutation-related-prognosis-in-b-cell-acute-lymphoblastic-leukemia-a-report-from-south-china-children-s-leukemia-group
#16
JOURNAL ARTICLE
Xinyu Li, Shaofen Lin, Ning Liao, Huirong Mai, Xingjiang Long, Lili Liu, Beiyan Wu, Qiwen Chen, Qian Kong, Xianling Kong, Lixia Liu, Jiayue Qin, Jianpei Fang, Dunhua Zhou
The next-generation sequencing technologies application discovers novel genetic alterations frequently in pediatric acute lymphoblastic leukemia (ALL). RAS signaling pathway mutations at the time of relapse ALL frequently appear as small subclones at the time of onset, which are considered as the drivers in ALL relapse. Whether subclones alterations in the RAS signaling pathway should be considered for risk group stratification of ALL treatment is not decided yet. In this work, we investigate the RAS signaling pathway mutation spectrum and the related prognosis in pediatric ALL...
May 2024: Hematological Oncology
https://read.qxmd.com/read/38560974/sickle-cell-disease-phenotypes-and-obstructive-sleep-apnea-are-they-related
#17
JOURNAL ARTICLE
Suhail Al-Saleh, Norah Alshehri, Sara Alsiddiqi, Mohmmed Rayis, Safa Eltahir, Khaled AlDajjam, Mohammed Alzaid, Wadha Alotaibi
OBJECTIVE: This study aims to compare the polysomnographic features between Arab-Indian and Benin phenotypes of sickle cell disease (SCD). MATERIALS AND METHODS: This prospective cross-sectional study was conducted in the Children's Hospital at King Fahad MedicalCity, in Riyadhwhere childrenwere recruited fromthe pediatric hematology clinic and pediatric sleepmedicine. All families were approached and patients who met the inclusion criteria and agreed to participate were included in the study...
March 22, 2024: Hematology/oncology and Stem Cell Therapy
https://read.qxmd.com/read/38558136/surgical-treatment-of-invasive-fungal-infection-in-pediatric-oncology
#18
JOURNAL ARTICLE
Fati Federica, Zambaiti Elisa, Petris Maria Grazia, Virgone Calogero, Dall' Igna Patrizia, Putti Maria Caterina, De Pieri Marica, Gamba Piergiorgio, Federica DeCorti
BACKGROUND: Invasive fungal disease (IFD) is typically aggressive and related with high mortality in children with a hematological malignancy. The association of medical and surgical treatment may ameliorate the outcome. The aim of this study was to analyze the surgical treatment of fungal infections in pediatric oncological populations. METHODS: Retrospective study (2000-2022) of a single-center experience. We reviewed the medical record of all patients with hematologic malignancies and IFD, analyzing the outcome...
April 1, 2024: European Journal of Haematology
https://read.qxmd.com/read/38556746/international-society-of-paediatric-oncology-siop-global-mapping-programme-latin-american-society-of-pediatric-oncology-slaop-country-level-report
#19
JOURNAL ARTICLE
Andrea Cappellano, Maite Gorostegui, Oscar Gonzalez-Ramella, Nevicolino Pereira Carvalho Filho, Diana Valencia, Luisa Chantada, Claudia Sampor, María J Serrano, Carla Macedo, Oscar Ramirez, Susan Sardinas, Eva Lezcano, Patricia Calderón, Yessika Gamboa, Ligia Fu, Wendy Gómez, Magdalena Schelotto, Cecilia Ugaz, Pablo Lobos, Simone Dos Santos Aguiar, Katiuska Moreno, Julia Palma, Gissela Sánchez, Filomena Moschella, Pascale Yola Heurtelou Gassant, Thelma Velasquez, Karina Quintero, Florencia Moreno, Milena Villarroel, Soad Fuentes Alabi, Liliana Vasquez, Julia Challinor, Guillermo L Chantada
BACKGROUND: Latin American countries are improving childhood cancer care, showing strong commitment to implement the Global Initiative for Childhood Cancer, but there are scant publications of the situation at a continental level. METHODS: As part of the International Society of Paediatric Oncology Global Mapping project, delegates of each country participating in the Latin American Society of Pediatric Oncology (SLAOP) and chairs of national pediatric oncology societies and cooperative groups were invited to provide information regarding availability of national pediatric cancer control programs (NPCCP), pediatric oncology laws, pediatric oncology tumor registries, and training programs and support to diagnosis and treatment...
March 31, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38556719/implementation-of-a-light-therapy-team-to-administer-photobiomodulation-therapy-a-standardized-protocol-to-prevent-and-treat-oral-mucositis-in-the-pediatric-hematopoietic-stem-cell-transplant-population
#20
JOURNAL ARTICLE
Kathleen Magee, Jenell Robins, Sharon Staton, Gabriella Llaurador, Alexandra M Stevens
BACKGROUND: Oral mucositis (OM) is a painful and common complication of hematopoietic stem cell transplant (HSCT). The Children's Oncology Group recently published guidelines recommending photobiomodulation (PBM) for preventing and treating OM in pediatric HSCT patients. However, this is a rarely used intervention in pediatric hospitals. PROCEDURE: Patients undergoing allogeneic HSCT, or autologous HSCT for a neuroblastoma diagnosis, had PBM administered from the first day of conditioning to transplant Day +20...
March 31, 2024: Pediatric Blood & Cancer
keyword
keyword
101179
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.